GNECCHI, MASSIMILIANO
 Distribuzione geografica
Continente #
NA - Nord America 6.092
AS - Asia 4.534
EU - Europa 3.553
SA - Sud America 620
Continente sconosciuto - Info sul continente non disponibili 230
AF - Africa 181
OC - Oceania 12
Totale 15.222
Nazione #
US - Stati Uniti d'America 5.919
CN - Cina 2.007
SG - Singapore 1.072
IE - Irlanda 824
IT - Italia 527
HK - Hong Kong 492
BR - Brasile 470
DE - Germania 434
RU - Federazione Russa 431
VN - Vietnam 403
FI - Finlandia 377
UA - Ucraina 238
FR - Francia 208
GB - Regno Unito 139
IN - India 132
SE - Svezia 121
ZA - Sudafrica 109
CA - Canada 93
BD - Bangladesh 65
JP - Giappone 56
AR - Argentina 54
MX - Messico 52
AT - Austria 47
TR - Turchia 41
ID - Indonesia 39
PL - Polonia 38
NL - Olanda 37
BE - Belgio 34
IQ - Iraq 30
ES - Italia 28
EC - Ecuador 26
MY - Malesia 22
PH - Filippine 21
CO - Colombia 20
PK - Pakistan 19
SA - Arabia Saudita 18
VE - Venezuela 17
KE - Kenya 16
AE - Emirati Arabi Uniti 15
JO - Giordania 14
LT - Lituania 12
UZ - Uzbekistan 12
MA - Marocco 11
MU - Mauritius 11
AU - Australia 9
CL - Cile 9
AL - Albania 8
CH - Svizzera 8
EG - Egitto 8
PE - Perù 8
PY - Paraguay 8
TN - Tunisia 8
AZ - Azerbaigian 6
BO - Bolivia 6
CZ - Repubblica Ceca 6
IL - Israele 6
IR - Iran 6
JM - Giamaica 6
KR - Corea 6
NP - Nepal 6
PT - Portogallo 6
BG - Bulgaria 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
EU - Europa 5
KG - Kirghizistan 5
SN - Senegal 5
CR - Costa Rica 4
KZ - Kazakistan 4
LB - Libano 4
OM - Oman 4
PA - Panama 4
TH - Thailandia 4
AO - Angola 3
BY - Bielorussia 3
CM - Camerun 3
HR - Croazia 3
KW - Kuwait 3
PS - Palestinian Territory 3
RO - Romania 3
RS - Serbia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BH - Bahrain 2
CY - Cipro 2
EE - Estonia 2
GE - Georgia 2
GI - Gibilterra 2
GT - Guatemala 2
LV - Lettonia 2
MK - Macedonia 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
BB - Barbados 1
BS - Bahamas 1
ET - Etiopia 1
GR - Grecia 1
Totale 14.983
Città #
Dublin 824
Chandler 686
San Jose 660
Singapore 593
Ashburn 572
Hong Kong 479
Beijing 425
Dallas 419
Nanjing 363
Jacksonville 319
New York 205
Boardman 200
Council Bluffs 181
Helsinki 166
Los Angeles 164
Wilmington 147
Princeton 145
Ho Chi Minh City 136
Lauterbourg 136
Lawrence 134
Nanchang 132
Munich 122
Hanoi 104
Changsha 103
Hebei 103
Pavia 101
Johannesburg 96
Shenyang 95
Medford 92
Shanghai 87
Jiaxing 86
Ann Arbor 76
Moscow 76
Hangzhou 71
Buffalo 66
Santa Clara 62
Milan 60
São Paulo 55
Redondo Beach 54
Nuremberg 53
Tokyo 49
Orem 45
Tianjin 45
Turku 43
Toronto 39
Frankfurt am Main 35
Warsaw 34
Brussels 29
Woodbridge 28
Chennai 27
Denver 26
Montreal 26
Brooklyn 25
The Dalles 25
Norwalk 23
Dearborn 22
Falls Church 22
Guangzhou 21
Rome 21
London 20
Seattle 20
Columbus 19
Fairfield 19
Mexico City 19
Atlanta 18
Boston 18
Falkenstein 18
Rio de Janeiro 18
Verona 18
Vienna 18
Belo Horizonte 17
Da Nang 17
Haiphong 17
Washington 17
Chicago 16
Mumbai 16
Amsterdam 15
Houston 15
Piscataway 15
Ankara 14
Nairobi 14
Phoenix 14
San Francisco 14
Zhengzhou 13
Amman 12
Baghdad 12
Manchester 12
Poplar 12
Stockholm 12
Quito 11
Caracas 10
Chieti 10
Jakarta 10
New Delhi 10
Redwood City 10
Tashkent 10
Bologna 9
Des Moines 9
Kunming 9
Lahore 9
Totale 9.819
Nome #
Identificazione di microRNA circolanti specificatamente sovra espressi in corso di infarto miocardico acuto. 252
Cellule staminali mesenchimali fetali isolate da placenta esercitano effetti paracrini cardioprotettivi. 208
Allogeneic Lethally Irradiated Cord Blood Mononuclear Cells in No-Option Critical Limb Ischemia: A “Box of Rain” 169
Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy 161
Correction to: Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy (Internal and Emergency Medicine, (2020), 15, 8, (1457-1465), 10.1007/s11739-020-02493-y) 157
Concomitant overexpression of IGF1 and BMP2 in mesenchymal stem cells mediates cytoprotection through both autocrine and paracrine activation of Akt, Erk1/2 and SMAD1/5/8 pathways. 155
Comparison of Outcomes of Staged Complete Revascularization Versus Culprit Lesion–Only Revascularization for ST-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease 136
Conditioned medium from human amniotic mesenchymal stromal cells limits infarct size and enhances angiogenesis 134
Rat experimental model of myocardial ischemia/reperfusion injury: an ethical approach to set up the analgesic management of acute post-surgical pain 133
Elevated serum uric acid is associated with a greater inflammatory response and with short- and long-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 132
Combined transcriptomic and proteomic approach identifies several putative paracrine factors of fetal mesenchymal stem cells. 132
Combination of miRNA499 and miRNA133 exerts a synergic effect on cardiac differentiation 132
Amyloidogenic light chains induce human cardiac fibroblast toxicity through alteration of mitochondrial functionality 131
Improved transduction efficiency of human amniotic mesenchymal stem cells using optimized lentiviral vectors 131
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy 129
Novel experimental protocol to study area at risk, infarct size, immunohistochemistry and tissue protein content on the same rodent heart. 127
Mesenchymal stem cell therapy for heart disease. 127
Paracrine mechanisms of mesenchymal stem cells in tissue repair 127
Adult stem cell-based therapy for the heart 126
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study 125
Combined Role of Troponin and Natriuretic Peptides Measurements in Patients With Covid-19 (from the Cardio-COVID-Italy Multicenter Study) 122
Identificazione di fattori paracrini e cardioprotettivi mediante analisi combinata del trascrittoma e del proteoma di cellule staminali mesenchimali fetali. 122
Overexpression of growth factors to improve cardiac differentiation of human mesenchymal stem cells derived from the amniotic membrane 122
Angiography- versus physiology-guided complete revascularization in patients with STEMI and multivessel disease: who's the better gatekeeper in this setting? 122
Donor Age Negatively Influences Cytoprotective but Not Proangiogenic Paracrine Properties of Human Mesenchymal Stem Cells. 121
Identification of cardioprotective factors produced by fetal mesenchymal stem cells through a combined transcriptomic and proteomic approach. 120
Smoker's paradox in ST-elevation myocardial infarction: Role of inflammation and platelets 120
Human fetal mesenchymal stem cells protect cardiac myocytes against hypoxia/reoxygenation injury 119
Impiego di cellule staminali mesenchimali in cardiologia. 119
Elevated serum uric acid is a predictor of contrast associated acute kidney injury in patient with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 118
Testing the paracrine properties of human mesenchymal stem cells using conditioned medium 117
Strategies for reducing door to balloon time in patients with acute myocardial infarction undergoing primary angioplasty: the Pavia experience 117
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 116
Favorable effect of glycoprotein IIbIIIa inhibitors among STEMI patients treated with primary PCI and incomplete ST resolution 116
Studio pilota sull'impiego di cellule CD133+ immunoselezionate per il trattamento di vasculopatie periferiche. 115
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene 115
Cord blood derived endothelial progenitor cells: time dependent in vitro generation capacity. 114
Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation 114
Enhancing the cardiomyogenic potential of human mesenchymal stem cells by modulation of miR expression. 114
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene 114
The cardioprotective paracrine effects exerted by human mesenchymal stem cells are negatively influenced by donor age 113
Protocols for in vitro differentiation of human mesenchymal stem cells into osteogenic, chondrogenic and adipogenic lineages 113
Prognostic Impact of in-Hospital-Bleeding in Patients With ST-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention 113
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation 113
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1 112
Gene and cell-based therapies for heart disease 111
L'età influenza negativamente gli effetti paracrini caridoprotettivi mediati da cellule staminali mesenchimali. 111
Cord blood derived endothelial progenitor cells: a superior buiding company in angiogenesis market. 111
Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model 111
Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis 110
Pentraxin-3 and galectin-1 are key mediators of the cardioprotective paracrine effects exerted by fetal mesenchymal stem cells isolated from human placenta 109
Proteotoxicity in cardiac amyloidosis: Amyloidogenic light chains affect the levels of intracellular proteins in human heart cells 109
Soluble factors released by human mesenchymal stem cells of fetal origin lead to cardiomyocyte protection through the inhibition of pro-apoptotic signaling 108
Enhancing stem cell therapy efficacy through genetic modification 108
The cardioprotective paracrine effects exerted by human mesenchymal stem cells are negatively influenced by donor age 107
IRES-based lentivirus co-espressing TGFbeta1 and FGF2 improves cell survival and angiogenesis in bone marrow-derived mesenchymal stem cells. 107
MicroRNA133 and microRNA499 exert synergistic effect on cardiac differentiation 107
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2 107
Direct oral Xa inhibitors versus warfarin in patients with cancer and atrial fibrillation: a meta-analysis 107
Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study 107
Novel IRES-based lentivirus co-expressing IGF1 and BMP2 enhances both cardiomyogenesis and cytoprotection of bone marrow-derived mesenchymal stem cells 105
Serum uric acid may modulate the inflammatory response after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction 105
La contemporanea overespressione di miRNA499 e miRNA133 induce il differenziamento in senso cardiomiocitario di cellule staminali pluripotenti. 104
The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2 104
Genotype-Phenotype Correlation in Induced Pluripotent Stem Cell (iPSC) Derived Cardiomyocytes Carrying Calmodulin Mutations 104
First-in-man case of non-invasive proton radiotherapy for the treatment of refractory ventricular tachycardia in advanced heart failure 103
PBMC microRNA-155 is up-regulated in chronic hemodialysis patients. 103
microRNA and Cardiac Regeneration 103
Synthetic extracellular matrix mimic hydrogel improves efficacy of mesenchymal stromal cell therapy for ischemic cardiomyopathy. 103
Long QT Syndrome modelling with cardiomyocytes derived from human-induced pluripotent stem cells 103
Cord blood-derived endothelial progenitor cells: a superior building company in the angiogenesis market: P599 103
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study 103
The unfavourable inflammatory response in elderly patients after myocardial infarction: should we talk of 'dysflammaging'? 102
Leptin affects the inflammatory response after STEMI 100
Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell mediated cardiac repair and functional improvement 99
Generation of two human induced pluripotent stem cell (hiPSC) lines from a long QT syndrome South African founder population 99
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi004-A from a carrier of the KCNQ1-R594Q mutation 99
Risk factors for primary ventricular fibrillation during a first myocardial infarction: Clinical findings from PREDESTINATION (PRimary vEntricular fibrillation and suDden dEath during firST myocardIal iNfArcTION) 99
Early Complete Revascularization in Hemodynamically Stable Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease 98
Mesenchymal stem cell therapy for heart disease. 97
Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction and conditioned media production 97
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi006-A from a patient affected by an autosomal recessive form of long QT syndrome type 1 97
Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries 94
Optimized lentiviral transduction of human amniotic mesenchymal stromal cells 94
Myocarditis in a 16-year-old boy positive for SARS-CoV-2 94
Has hyperglycemia a different prognostic role in STEMI patients with or without diabetes? 94
Neutrophil to platelet ratio: a novel prognostic biomarker in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention 92
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study 92
Barriers associated with emergency medical service activation in patients with ST-segment elevation acute coronary syndromes 92
Cell Therapy for Heart Regeneration: Learning from the Past to Build a Brighter Future 91
Sex-related differences in patients with coronavirus disease 2019: results of the Cardio-COVID-Italy multicentre study 89
Insertion/deletion polymorphism of the Angiotensin I-Converting Enzyme gene and risk of restenosis after directional coronary atherectomy followed by stent implantation 88
The prognostic value of serial troponin measurements in patients admitted for COVID-19 88
Paracrine mechanisms of stem cell reparative and regenerative actions in the heart 87
Soluble factors released by human mesenchymal stem cells of fetal origin lead to cardiomyocyte protection through the inhibition of pro-apoptotic signaling 86
Identification of upregulated microRNAs in the plasma of patients with acute myocardial infarction 86
the procardiomyogenic effect of miR499 is sinergistically enhanced by miR133. 86
Induced pluripotent stem cell technology: Toward the future of cardiac arrhythmias 86
MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes 86
Human mesenchymal stromal cells do not express ACE2 and TMPRSS2 and are not permissive to SARS-CoV-2 infection 85
Totale 11.315
Categoria #
all - tutte 65.648
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.648


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022582 0 9 26 7 15 23 9 46 45 16 92 294
2022/20232.151 225 155 37 131 207 211 5 116 950 22 55 37
2023/2024953 99 177 33 62 84 270 33 52 6 40 56 41
2024/20252.482 63 173 37 55 79 148 160 162 625 77 312 591
2025/20265.801 498 429 611 580 760 227 1.044 272 616 423 186 155
2026/2027321 104 217 0 0 0 0 0 0 0 0 0 0
Totale 15.222